Strategic Leader, Early Development Assets

Ipsen Biopharm Ltd; Greater London; Vor Ort; GBP 120.000 - 180.000; Vollzeit

Zusammenfassung

Ipsen Biopharm Ltd. is seeking an Early Development Asset Lead to drive integrated development strategy and execution for one or more early-stage assets from nomination through first-in-human trials.

The role leads the Early Development Asset Team, coordinating clinical, regulatory, CMC, translational, pharmacology, and safety inputs to advance programs with scientific rigor and portfolio alignment.

Qualifikationen

• PhD, MD, PharmD or equivalent with 10–15 years in multidisciplinary drug development.
• Experience leading cross-functional early development teams.
• Oncology knowledge with IO or ADCs desirable.
• Experience with regulatory filings (IND/CTA) and health authority interactions.

Aufgaben

• Lead one or more Early Development Asset Teams with integrated program strategy.
• Own and align preclinical, translational, clinical, regulatory and diagnostic plans.
• Present data and options to governance bodies with scientific credibility.

Kenntnisse

Leadership

Cross-functional collaboration

Program management

Communication (English)

Strategic thinking

Stakeholder management

Ausbildung

PhD/MD/PharmD or equivalent

Jobbeschreibung

Ipsen Biopharm Ltd. is seeking an Early Development Asset Lead to drive integrated development strategy and execution for one or more early-stage assets from nomination through first-in-human trials.

The role leads the Early Development Asset Team, coordinating clinical, regulatory, CMC, translational, pharmacology, and safety inputs to advance programs with scientific rigor and portfolio alignment.